Ask The Pharmacist: New OTC Opioid Alternative Available for Pain Medication
Can Tylenol and naproxen be taken together? Enlyte's pharmacist explains medication safety considerations for managing pain in workers' compensation.
The State of Pharmacy Trends in Workers' Comp and Auto Casualty
Discover the latest pharmacy trends impacting workers’ compensation and auto casualty, from rising drug costs to emerging challenges. Register for our webinar to gain expert insights and actionable strategies.
The Pharmacy Blind Spot Created by Opportunistic Products
In this Enlyte Envision Podcast, Cameron Hannum, Pharm.D., Sr. Clinical Account Pharmacist, examines opportunistic products, high-cost topicals and the out-of-network channels where these costs can be harder to manage.
Topical Medication Trends
Examining utilization and spend across in-network and out-of-network channels captures the full scope of topical prescribing patterns. While in-network data reflects the effectiveness of clinical controls, out-of-network topical trends expose significant factors that complicate cost containment. Together, these perspectives reveal where topical spend is concentrated, and where intervention can deliver meaningful savings.
Ask The Pharmacist: Medication-Related Fall Risk in Workers’ Compensation Claims
A fall can quickly change the direction of a workers’ compensation claim, and their consequences can be significant. Falling during recovery can result in new injuries, delayed healing, additional medical treatment and extended time away from work. Workplace hazards and physical limitations are known contributors to falls, but one important risk factor frequently overlooked is medication.
Turning Early Signals Into Earlier Action Through Connected Claim Intelligence
How connected claim intelligence can help workers’ comp teams identify risk earlier, act with greater confidence and improve outcomes.
Fewer Prescriptions, Bigger Price Tags
Prescription utilization in workers’ comp continues to decline, but that doesn’t mean drug costs are no longer a concern. In fact, the latest Enlyte Drug Trends Report finds a small number of high-cost prescriptions are creating an outsized impact. In today’s Enlyte Envision podcast, Brian Allen explores what’s driving these costs, how some providers are exploiting gaps in the system and what states can do to rein in abusive pricing.
Stay Ahead in P&C
Get monthly insights from Enlyte experts to tackle your toughest claims challenges.